Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Stem Cell/Cord Blood Banking Market In 2029?

The market for stem cell/cord blood banking has experienced significant growth in the past few years. The change is expected from $12.26 billion in 2024 to $13.36 billion in 2025, manifesting a compound annual growth rate (CAGR) of 9.0%. The growth during the past period was facilitated by factors like progress in medical technology, increased public awareness, successful clinical applications, supportive regulatory measures, and research funding.

What Growth Rate Is Forecasted for the Stem Cell/Cord Blood Banking Market by 2029?

The market size for stem cell/cord blood banking is projected to experience swift growth in the upcoming years. The market is expected to reach a value of $21.78 billion in 2029 with a compound annual growth rate (CAGR) of 13.0%. The surge in growth in the prediction period is linked to factors such as personalized medicine, emerging therapies, global expansion, biotechnology investments, and a legal and ethical framework. Non-invasive collection methods, a range of banking services, clarity and regulation, team efforts and storage advancements are the main trends forecasted for this period.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2514&type=smp

Which Key Companies Are Shaping the Future of the Stem Cell/Cord Blood Banking Market?

Major companies operating in the stem cell/cord blood banking market include AMAG Pharmaceuticals Inc., Cryo-Cell International Inc., Esperite NV, Americord Registry LLC, China Cord Blood Corporation, Cordlife Group Ltd., CordVida, Cryo Stemcell, PerkinElmer Inc., ReeLabs Pvt Ltd., Smart Cells International Ltd., Stemade Biotech Pvt Ltd., ViaCord Inc., Americord Registry LLC, LifeCell International, Cryoviva Biotech Pvt Ltd., Cytori Therapeutics Inc., Thermo Fisher Scientific Inc., Cord Blood America Inc., StemCyte Inc., Brainstorm Cell Therapeutics Inc., Cord Blood Registry Systems Inc., Healthbanks Biotech Usa Inc., Cryo-save Private Ltd., New York Cord Blood Center, CryoHoldco, Vita 34 International AG, Reliance Life Sciences Pvt Ltd., Maze Cord Blood Laboratories, Cells4Life Group LLP

Which Factors Are Driving Demand in the Stem Cell/Cord Blood Banking Industry?

The surge in the number of cancer patients is significantly contributing to the expansion of the stem cell/cord blood banking market. Diseases like leukemia and multiple myeloma can be treated using stem cell transplants. The process can involve an autologous transplant where the stem cells of the patient receiving the transplant are used, or an allogeneic transplant where the stem cells are extracted from a related or unrelated donor who is a match. The valuable use of stem cells in cancer therapy helps to revive the blood-forming stem cells that get damaged during chemotherapy. For example, as stated by the American Cancer Society, a US-based non-profit cancer advocacy organization, in January 2023 the count of cancer cases rose to 1,958,310 in 2023. This is a growth of 3.16% from 1,898,160 in 2021. Therefore, the escalating number of cancer patients is fueling the growth of the stem cell/cord blood banking market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2514&type=smp

How Is the Stem Cell/Cord Blood Banking Market Segmented by Several Divisions?

The stem cell/cord blood banking market covered in this report is segmented –

1) By Cell Type: Adult Stem Cells, Umbilical Cord Blood Stem Cells, Embryonic Stem Cells

2) By Service: Collection, Processing, Analysis, Storage

3) By Bank Type: Public, Private

4) By Application: Leukemia, Anemia, Thalassemia, Autism, Cerebral Palsy, Diabetes, Other Applications

Subsegments:

1) By Adult Stem Cells: Hematopoietic Stem Cells (HSC), Mesenchymal Stem Cells (MSC), Neural Stem Cells (NSC), Induced Pluripotent Stem Cells (iPSCs)

2) By Umbilical Cord Blood Stem Cells: Hematopoietic Stem Cells (HSC) From Cord Blood, Mesenchymal Stem Cells (MSC) From Cord Blood

3) By Embryonic Stem Cells: Embryonic Stem Cells (ESCs) From Human Embryos, Stem Cells Derived From Human Embryonic Germ Cells

What are the Emerging Market Trends Driving the Growth of the Stem Cell/Cord Blood Banking Industry?

The combination of cord blood and tissue storage with genetic testing services is a growing trend in the stem cell/cord blood banking industry. This is feasible and effective due to its supplementary services provided to current clients, aiding in the expansion of their product offerings. For instance, the genetic testing corporation Natera introduced the Evercord service for cord blood and tissue storage. This service permits soon-to-be parents to gather, preserve, and potentially access their newborn’s cord blood and tissue for therapeutic utilization in transplantation and regenerative medical applications.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

Which Regions Are Driving Growth in the Stem Cell/Cord Blood Banking Market?

North America was the largest region in the stem cell/cord blood banking market in 2023. Western Europe was the second largest region in the stem cell/cord blood banking market analysis. The regions covered in the stem cell/cord blood banking market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2514

This Report Delivers Insight On:

1. How big is the stem cell/cord blood banking market, and how is it changing globally?

2. Who are the major companies in the stem cell/cord blood banking market, and how are they performing?

3. What are the key opportunities and risks in the stem cell/cord blood banking market right now?

4. Which products or customer segments are growing the most in the stem cell/cord blood banking market?

5. What factors are helping or slowing down the growth of the stem cell/cord blood banking market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model